Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 17,635 | 14,774 | 10,739 | 8,717 | 0 |
| Cost of Goods | 2,011 | 1,708 | 1,993 | 1,598 | N/A |
| Gross Profit | 15,624 | 13,066 | 8,746 | 7,119 | N/A |
| Operating Expenses | 13,022 | 9,345 | 9,131 | 8,039 | 0 |
| Operating Income | 2,613 | 4,429 | 608 | -322 | N/A |
| Interest Expense | 766 | 1,088 | 1,693 | 1,024 | 0 |
| Other Income | 280 | 2,508 | -184 | -12 | 0 |
| Pre-tax Income | 2,127 | 5,849 | -1,269 | -1,358 | 0 |
| Net Income Continuous | 2,055 | 5,849 | -1,269 | -1,358 | N/A |
| Net Income | $2,055 | $5,849 | $-1,269 | $-1,358 | $N/A |
| EPS Basic Total Ops | 2.19 | 0.43 | -1.05 | -1.22 | N/A |
| EPS Basic Continuous Ops | 1.45 | 0.46 | -0.59 | -0.71 | N/A |
| EPS Diluted Total Ops | 2.01 | 0.05 | -1.05 | -1.22 | N/A |
| EPS Diluted Continuous Ops | 1.50 | 0.41 | -0.59 | -0.71 | N/A |
| EBITDA(a) | $2,947 | $4,961 | $1,611 | $92 | $N/A |